Cancer Breakthroughs Tracker — Watchboard UpdatesLatest data updates for Cancer Breakthroughs Tracker.https://watchboard.dev/en-usBreaking: FDA Rejects Replimune Drug Again; Revolution Medicines Pancreatic Cancer Pill Advanceshttps://watchboard.dev/cancer-breakthroughs/#digest-2026-04-13/https://watchboard.dev/cancer-breakthroughs/#digest-2026-04-13/GSK advances ovarian cancer drug mo-rez through clinical pipeline with positive momentum. FDA issues second rejection of Replimune's cancer drug while Revolution Medicines' pancreatic cancer pill continues to advance.Mon, 13 Apr 2026 00:00:00 GMTbreaking